Entourage Health and LiUNA Pension Fund Upsize Credit Facility with Additional $30 Million in Non-Dilutive Funding Availability
Entourage Health Corp. is pleased to announce it has amended and upsized its existing credit facility with an affiliate of the LiUNA Pension Fund of Central and Eastern Canada, adding an additional $30 million in funding availability.
Entourage Launches New Suite of 15 Innovative Color Cannabis and Saturday Cannabis Products for its Largest Retail Product Call to Date
Entourage Health Corp. is pleased to announce the expansion of its premium brand portfolio releasing its most extensive suite of new products into the Canadian market to date.
Entourage Launches Unique Medical Cannabis Marketplace “Syndicate” Offering Premium Craft Products From Collective of In-House and Third-Party Micro Producers
Entourage Health Corp. is pleased to announce the launch of Syndicate a direct-to-patient medical cannabis marketplace showcasing a portfolio of premium craft cannabis products sourced both in-house and from third-party micro-cultivators and producers.
Entourage Health Appoints Seasoned Executive James Afara to Chief Operating Officer
Entourage Health Corp. is pleased to announce the appointment of James Afara as the Company’s Chief Operating Officer (COO).
Entourage Health Signs Four New Union Groups to its Starseed Medicinal Program
Entourage Health Corp. is pleased to announce its medical subsidiary Starseed Medicinal has added four new union groups to its full-service, proprietary medical cannabis program, in partnership with leading benefits provider Union Benefits – the administrator of union group benefits to over 12,000 members.
Entourage Health Reports Second Quarter 2022 Financial Results
Entourage announced today its financial results for the three and six months ended June 30, 2022.
Entourage Health Announces Second Quarter 2022 Financial Results Call to be held on August 30, 2022
Entourage Health Corp. announced today it will file its second quarter 2022 financial statements and management’s discussion and analysis after-market on Monday, August 29, 2022.
Entourage Health Signs Exclusive Licensing Agreement with Irwin Naturals to Produce and Distribute its Cannabis Products in Canada
Entourage Health Corp. is pleased to announce it has entered into an exclusive licensing, manufacturing and distribution agreement with Irwin Naturals Inc., a renowned nutraceuticals and herbal supplement formulator of popular branded wellness products sold across North America.
Entourage Health Provides Update on Credit Facilities’ Maturity Dates and Amends Outstanding Unsecured Convertible Debentures
Entourage Health Corp. confirmed today it has satisfied certain conditions in connection with the recent amendments to its existing senior secured credit facility entered into on March 29, 2019 between the Company and Bank of Montreal, and its existing second secured credit facility with an affiliate of the LiUNA Pension Fund of Central and Eastern Canada, entered into on September 30, 2020.
Entourage Expands Medical Offerings with Launch of New Services and Products
Entourage Health Corp. is pleased to announce the expansion of its Starseed Medicinal offerings and services as it partners with HelloMD, a leading online cannabis telehealth Company, to expand patient access to experienced and knowledgeable healthcare practitioners across Canada.
Entourage Health Announces Amendments to its Credit Facilities to Improve Debt Position and Support Strategic Long-Term Growth
Entourage Health Corp. is pleased to announce it has amended its existing senior secured credit facility entered into on March 29, 2019 between the Company and Bank of Montreal, and its existing second secured credit facility with an affiliate of the LiUNA Pension Fund of Central and Eastern Canada, entered into on September 30, 2020.
Entourage Health Announces $8.9 Million Upsize to Credit Facility and Implementation of Proposed Amendments to 8.5% Unsecured Convertible Debentures
Entourage Health Corp. announced today it has amended and upsized its existing credit facility with an affiliate of the LiUNA Pension Fund of Central and Eastern Canada, adding an additional $8.9 million in non-dilutive funding availability.
Entourage Health Provides Update on Proposed Amendments to its 8.5% Unsecured Convertible Debentures
Entourage Health Corp. is pleased to provide an update on the previously announced proposed amendments to the trust indenture dated as of September 25, 2019 between TSX Trust Company and the Company governing the Company’s 8.5% unsecured convertible debentures due September 25, 2022.
Entourage Health Announces Debentureholders Overwhelmingly Approve Proposed Amendments to 8.5% Unsecured Convertible Debentures
Entourage Health Corp. is pleased to announce that holders of the Company’s 8.5% unsecured convertible debentures due September 25, 2022, overwhelmingly approved the previously announced proposed amendments to the trust indenture dated as of September 25, 2019 between TSX Trust Company and the Company governing the Debentures.
Entourage Announces Results of 2022 Annual General Meeting of Shareholders
Entourage Health Corp. is pleased to announce that shareholders overwhelmingly approved all proposed resolutions at its annual general and special meeting of shareholders (“AGM”) held virtually in Toronto, Ontario on June 10, 2022.
Entourage Health Extends its Senior Secured Credit Facility Maturity Date
Entourage Health Corp. confirmed today it has signed an additional amendment to its senior secured credit facility entered into on March 29, 2019.
Entourage Health Reports Record First Quarter 2022 Financial Results
Entourage Health Corp. announced today its financial results for the three months ended March 31, 2022.
Entourage Health Announces Canadian Debut of The Boston Beer Company’s New Cannabis-Infused Iced Tea Beverages ‘TeaPot’
Entourage Health Corp. and The Boston Beer Company, Inc. are pleased to announce the Canadian debut of ‘TeaPot’, a new line of cannabis-infused iced tea beverages.
Entourage Health Reaffirms First Quarter 2022 Preliminary Record Revenues of $17.4 Million and Announces Financial Results Call to be held on May 31, 2022
Entourage Health Corp. announced today that it is scheduled to file its first quarter 2022 financial statements and management’s discussion and analysis after-market on Monday, May 30, 2022.
Entourage Health Enters into Voting Support Agreement and Announces Proposed Amendments to its 8.5% Unsecured Convertible Debentures
Entourage Health Corp. is pleased to announce that it has entered into voting support agreements with certain holders of the Company’s 8.5% unsecured convertible debentures due September 25, 2022…